James Boyle
Tracked across 2 events · 12 articles · First seen May 27, 2026 · Last active Jul 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: James Boyle, as CEO, will be presenting at the Goldman Sachs 47th Annual Global Healthcare Conference, representing United States — MedlinePlus to investors.
May 27, 2026 · 6 articles
Regulatory
Impact: James Boyle is the CEO of Medline who received the FDA warning letter; his leadership is under scrutiny regarding the quality control failures.
Jul 01, 2026 · 6 articles
ERGEN INTELLIGENCE
Track James Boyle live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard